海外の治験の状況「多発性骨髄腫」での検索結果
49件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- A study in Patients with Previously Treated Multiple Myeloma
- Previously Treated Multiple Myeloma br>MedDRA version: 14.1 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Brazil, Canada, Germany, Greece, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Spain, Taiwan, Turkey, United Kingdom, United States
- 2012-04-02
Recruiting
- A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
- Smoldering Multiple Myeloma
- Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom, United States
- 2017-09-29
Not recruiting
- A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Australia, Brazil, Canada, Czechia, France, Greece, Israel, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Sweden, Taiwan, Ukraine, United Kingdom, United States
- 2017-09-07
Recruiting
- Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis
- Multiple Myeloma
- Brazil
- 2018-04-19
Not recruiting
- Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
- Multiple Myeloma;Renal Insufficiency;Multiple Myeloma;Renal Insufficiency;Multiple Myeloma;Renal Insufficiency;Multiple Myeloma;Renal Insufficiency
- Brazil, Germany, Korea, Republic of, Russian Federation, Spain, Thailand, Turkey, United Kingdom, United States
- 2011-04-12
Recruiting
- An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
- Multiple Myeloma
- Belgium, Brazil, China, Colombia, France, Germany, Greece, Israel, Italy, Mexico, Spain, Taiwan, Turkey, United Kingdom, United States
- 2016-04-28
Not recruiting
- Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
- Multiple Myeloma
- Brazil, Italy, Japan, Russian Federation, Spain, United Kingdom, United States
- 2015-06-15
Recruiting
- Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- Plasma Cell Myeloma
- Australia, Brazil, Canada, Czechia, France, Greece, Hungary, Italy, Spain, United States
- 2017-06-19
Not recruiting
- BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
- Multiple Myeloma
- Argentina, United States
- 2006-06-28
Not recruiting
- Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma
- Stage I Multiple Myeloma;Stage II Multiple Myeloma;Stage III Multiple Myeloma;Stage I Multiple Myeloma;Stage II Multiple Myeloma;Stage III Multiple Myeloma;Stage I Multiple Myeloma;Stage II Multiple Myeloma;Stage III Multiple Myeloma;Stage I Multiple Myeloma;Stage II Multiple Myeloma;Stage III Multiple Myeloma
- Australia, Peru, Puerto Rico, South Africa, United States
- 2004-01-09
